Non-viral Autologous Cell Therapy
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
68
NCT05312801
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 21, 2023
Completion: Sep 2, 2025
NCT05546723
LMY-920 for Treatment of Relapsed or Refractory Myeloma
Start: Mar 13, 2024
Completion: Oct 31, 2025
NCT06340750
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
Start: Apr 1, 2025
Completion: Jun 15, 2026
Loading map...